Clinical trial
Randomized Clinical Trial, Double-blind, Dose-escalating of Drug Intensities, Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
NCT04049630 is registered in ClinicalTrials.gov with Programme National de Lutte contre l'Onchocercose, Republic of the Congo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Clinical Trial, Double-blind, Dose-escalating of Drug Intensities, Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
- Lead sponsor
- Programme National de Lutte contre l'Onchocercose, Republic of the Congo
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 16, 2021
- Completion date
- July 15, 2021
- Enrollment
- 255 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.